PRQR (ProQR Therapeutics N.V. Ordinary Shares) Stock Analysis - SEC Filings

ProQR Therapeutics N.V. Ordinary Shares (PRQR) is a publicly traded Healthcare sector company. As of May 21, 2026, PRQR trades at $1.49 with a market cap of $159.10M and a P/E ratio of 0.00. PRQR moved +0.00% today. Year to date, PRQR is -29.90%; over the trailing twelve months it is -18.75%. Its 52-week range spans $1.07 to $4.62. Analyst consensus is strong buy with an average price target of $8.20. Rallies surfaces PRQR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find PRQR SEC filings?

Rallies organizes PRQR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

PRQR Key Metrics

Key financial metrics for PRQR
MetricValue
Price$1.49
Market Cap$159.10M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$4.62
52-Week Low$1.07
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest PRQR News

PRQR Analyst Consensus

5 analysts cover PRQR: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.20.

Common questions about PRQR

Where can I find PRQR SEC filings?
Rallies organizes PRQR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show PRQR 10-K and 10-Q filings?
Rallies organizes PRQR SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is PRQR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PRQR. It does not provide personalized investment advice.
PRQR

PRQR